|
(1E,3S,9Z,11aR,12S,14R,14aR)-3,6,7,8,11,11a,12,13,14,14a-Decahydro-12,14-dihydroxy-3-(2-phenylethyl)-5H-cyclopent[e]oxacyclotridecin-5-one Suppliers list
|
|
| | (1E,3S,9Z,11aR,12S,14R,14aR)-3,6,7,8,11,11a,12,13,14,14a-Decahydro-12,14-dihydroxy-3-(2-phenylethyl)-5H-cyclopent[e]oxacyclotridecin-5-one Basic information |
| Product Name: | (1E,3S,9Z,11aR,12S,14R,14aR)-3,6,7,8,11,11a,12,13,14,14a-Decahydro-12,14-dihydroxy-3-(2-phenylethyl)-5H-cyclopent[e]oxacyclotridecin-5-one | | Synonyms: | (1E,3S,9Z,11aR,12S,14R,14aR)-3,6,7,8,11,11a,12,13,14,14a-Decahydro-12,14-dihydroxy-3-(2-phenylethyl)-5H-cyclopent[e]oxacyclotridecin-5-one;17-Phenyl-18,19,20-trinorPGF2α 1,15-lactone;17-Phenyl-18,19,20-trinorprostaglandin F2α 1,15-lactone;17-Phenyl-18,19,20-trinor-PGF2α 1,15-Lactone;5H-Cyclopent[e]oxacyclotridecin-5-one, 3,6,7,8,11,11a,12,13,14,14a-decahydro-12,14-dihydroxy-3-(2-phenylethyl)-, [3S-(1E,3R*,9Z,11aS*,12R*,14S*,14aS*)]- (9CI) | | CAS: | 62411-15-8 | | MF: | C23H30O4 | | MW: | 370.48 | | EINECS: | | | Product Categories: | | | Mol File: | 62411-15-8.mol | ![(1E,3S,9Z,11aR,12S,14R,14aR)-3,6,7,8,11,11a,12,13,14,14a-Decahydro-12,14-dihydroxy-3-(2-phenylethyl)-5H-cyclopent[e]oxacyclotridecin-5-one Structure](CAS/GIF/62411-15-8.gif) |
| | (1E,3S,9Z,11aR,12S,14R,14aR)-3,6,7,8,11,11a,12,13,14,14a-Decahydro-12,14-dihydroxy-3-(2-phenylethyl)-5H-cyclopent[e]oxacyclotridecin-5-one Chemical Properties |
| | (1E,3S,9Z,11aR,12S,14R,14aR)-3,6,7,8,11,11a,12,13,14,14a-Decahydro-12,14-dihydroxy-3-(2-phenylethyl)-5H-cyclopent[e]oxacyclotridecin-5-one Usage And Synthesis |
| Uses | 17-Phenyl-18,19,20-trinor-PGF2α 1,15-Lactone is an impurity of Bimatoprost (B386800), which is an antiglaucoma agent. Bimatoprost is an synthetic prostamide; structurally related to prostaglandin F2α. |
| | (1E,3S,9Z,11aR,12S,14R,14aR)-3,6,7,8,11,11a,12,13,14,14a-Decahydro-12,14-dihydroxy-3-(2-phenylethyl)-5H-cyclopent[e]oxacyclotridecin-5-one Preparation Products And Raw materials |
|